This became the most interesting field now a days with the evolving nature of microbes. To know the information of an infection and its epidemiology etc the genomic study of the microbial strains is the only way to study about the disease further. Thus it plays a major role in prognosis, drug development, diagnosis and its epidemic control etc
Market Analysis: The Movement Disorders market is projected for substantial growth between 2025 and 2030, driven by increasing global prevalence, an aging population, and continuous advancements in diagnostics and therapeutics. The overall market is estimated to reach $11,067 million by 2030, reflecting a CAGR of 7.90% during the 2024-2030 period.Within this, individual segments show varied growth. The Parkinson's Disease Treatment Market is expected to grow at a CAGR of 3.58% to 7.45%. The Huntington's Disease Treatment Market is poised for significant expansion, with CAGRs broadly ranging from 7.8% to an impressive 23.8%, fueled by substantial R&D in disease-modifying therapies like gene therapies.
